Short description
This kit is used for the qualitative detection of SARS-CoV-2, respiratory syncytial virus and influenza A&B antigens in vitro, and can be used for the differential diagnosis of SARS-CoV-2 infection, respiratory syncytial virus infection, and influenza A or B virus infection[1]. The test results are for clinical reference only and cannot be used as the sole basis for diagnosis and treatment.
Epidemiology
Novel coronavirus (2019, COVID-19), referred to as "COVID-19", refers to pneumonia caused by novel coronavirus (SARS-CoV-2) infection.
Respiratory syncytial virus (RSV) is a common cause of upper and lower respiratory tract infections, and it is also the main cause of bronchiolitis and pneumonia in infants.
According to the antigenicity difference between core-shell protein (NP) and matrix protein (M), influenza viruses are classified into three types: A, B and C. Influenza viruses discovered in recent years will be classified as D. Among them, A and B are the main pathogens of human influenza, which have the characteristics of wide epidemic and strong infectivity, causing serious infections and life-threatening in children, the elderly and people with low immune function.
Technical Parameters
Target region - SARS-CoV-2, Respiratory Syncytium, Influenza A&B Antigen
Storage temperature - 4-30 ℃ sealed and dry for storage
Sample type - Nasopharyngeal swab、Oropharyngeal swab、Nasal swab
Shelf life - 24 months
Auxiliary instruments - Not required
Extra Consumables - Not required
Detection time - 15-20 mins